Coffee consumption has been correlated with a decreased risk of developing Alzheimer’s disease (AD) and Parkinson’s disease (PD). A new study is the first to show that a compound found in brewed coffee may elicit neuroprotective effects by inhibiting the aggregation of amyloid-beta and tau.
No comments:
Post a Comment